3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
11
Breast Neoplasms
10
Prostatic Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Skin Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity-Related Malignant Neoplasm
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Syndrome
1
Substance-Related Disorders
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Primary Myelofibrosis
1
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
avelumab
6
Docetaxel
6
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Educational Status
×
90 days
×
Clear all
No trials found.